Abstract: Bi-specific fusion proteins with therapeutic uses are provided, as well as pharmaceutical compositions comprising such fusion proteins, and methods for using such fusion proteins to repair or regenerate damaged or diseased tissue. The bi-specific fusion proteins generally comprise: (a) a targeting polypeptide domain that binds to a target molecule; and (b) an activator domain that detectably modulates tissue regeneration.

Abstract: Various embodiments disclosed relate to methods of separating impurities from industrial minerals using electrocoagulation and apparatuses for performing the same. In one embodiment, the present invention provides a method of purifying an industrial mineral composition. The method can include obtaining or providing an aqueous slurry comprising a mineral composition comprising one or more industrial minerals and one or more impurities. The method can include subjecting the aqueous slurry to an electrical current to form at least one coagulation comprising the one or more impurities. The method can include separating at least one of the coagulations from the one or more minerals, providing a purified mineral composition.

Abstract: Various embodiments disclosed relate to methods of separating impurities from industrial minerals using electrocoagulation and apparatuses for performing the same. In one embodiment, the present invention provides a method of purifying an industrial mineral composition. The method can include obtaining or providing an aqueous slurry comprising a mineral composition comprising one or more industrial minerals and one or more impurities. The method can include subjecting the aqueous slurry to an electrical current to form at least one coagulation comprising the one or more impurities. The method can include separating at least one of the coagulations from the one or more minerals, providing a purified mineral composition.